A National Institute of Health review of treatment strategies for early onset schizophrenia that will appear in Frontiers in Child and Neurodevelopmental Psychiatry finds that although “second-generation antipsychotics remain the mainstay of treatment … current medications provide suboptimal response at best.” The authors recommend, based on the adult literature, adding psychotherapeutic intervention for “a more comprehensive treatment strategy.”
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.